Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2023 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.
-
Shrinking team NBB
FTE fell two years in a row, from 3.5 to 0.
-
Busy address KBO
10 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
SBM Life Science from Machelen (Brab.), company number BE0660683727, closed financial year 2025 with a result of € -126,723 after tax. For that financial year SBM Life Science recorded a gross margin of € 49,680 and equity of € -2.2 million. Compared with financial year 2023, the result moved from € -311,740 to € -126,723. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ -2.2 million
▼ € 240,383 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -126,723
▲ 59 % less loss than in 2023
Profit after tax over the fiscal year.
€ 171,541
▲ € 136,343 vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -2.2 million.
People and assets in 2025
0
▼ 0.9 vs 2023
Average over the fiscal year, from the social balance sheet.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 193,166
▼ 66% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 59,737
▲ 17% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2025 | Change 2023 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 1,609,045 | € 1,171,962 | € 1,067,289 | - | |
| Gross margin | € 298,507 | € 396,185 | € -65,071 | € 49,680 | ▲ € 114,750 |
| Profit after taxes | € -160,813 | € -84,016 | € -311,740 | € -126,723 | ▲ € 185,016 |
| Equity | € -1,544,232 | € -1,628,248 | € -1,939,988 | € -2,180,371 | ▼ € 240,383 |
| Total debts | € 2,792,197 | € 3,023,430 | € 2,619,120 | € 2,571,797 | ▼ 2% |
| Cash | € 69,366 | € 33,352 | € 35,198 | € 171,541 | ▲ € 136,343 |
| Retained profit | € -1,550,432 | € -1,634,448 | € -1,946,188 | € -2,186,571 | ▼ € 240,383 |
| Bank debt | € 113,910 | € 39,413 | € 0 | € 0 | |
| Balance sheet total | € 1,278,833 | € 1,413,475 | € 697,425 | € 409,719 | ▼ 41% |
| Employees (FTE) | 3.3 | 3.5 | 0.9 | 0 | ▼ 0.9 |
Key figures of SBM Life Science, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to SBM Life Science?
What happened at SBM Life Science in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 126,723. filed late Source: NBB ↗
- SBM Jardin SAS became a director. NBB
- New establishment in Machelen (Brab.). KBO
- Start of the company according to the CBE. KBO
In short
From € 160,813 loss in 2021 to € 126,723 loss in 2025.
Paid € 56,259 in corporate taxes since 2021.
On average € 113,200 of value added per employee in 2022.
Management
Behind SBM Life Science is SBM Jardin SAS.
Directors
According to the 2025 annual accounts
Director · represented by Jean-Paul Simmler
since 2023
Establishments
Establishment units
Physical locations of this company
De Kleetlaan 5 BC
1831 Machelen (Brab.)
Pegasuslaan 5
1831 Machelen (Brab.)
Active since 3 August 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
All companies at this address →Cohesity Belgium
€ 4.8 million revenue · 2025
EXPRELEC
€ 35,174 gross margin · 2025
ELM'S VISION
€ 54,844 gross margin · 2024
DEEL PAYMENTS EUROPE
€ 234,976 gross margin · 2025
Silk Road Partners
€ -525 gross margin · 2025
+5 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0660.683.727
- VAT number
- BE 0660.683.727
- Registered office
- De Kleetlaan 5 BC, 1831 Machelen (Brab.)
- Names & denominations
- SBM Life Science
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 August 2016
- Peppol
- Active · Active since 23 Dec 2025
- Activities · NACE
Handelsbemiddeling in de groothandel in brandstoffen, ertsen, metalen en chemische producten
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Groothandel in kunstmeststoffen en andere agrochemische producten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied